[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]
[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]
[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]
[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-5101287 (State of other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) No. 588 Shiji Xi Road, Xianyang, Shaanxi Province, The People’s Republic of China 712046 (Zip Code) Biostar Pharmaceuticals, Inc. 2009 Incentive Stock Plan (Full Title of Plan) Mr. Ronghua Wang No. 588 Shiji] [BIOSTAR PHARMACEUTICALS, INC. 2009 INCENTIVE STOCK PLAN This Biostar Pharmaceuticals, Inc. 2009 Incentive Stock Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee "] [August 28, 2009 Biostar Pharmaceuticals, Inc. Xianyang, Shaanxi Province The People’s Republic of China 712046 Ladies and Gentlemen: Very truly yours, Sichenzia Ross Friedman Ference LLP Title 41 EX-5.1 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM We consent to the incorporation by reference in this registration statement of Biostar Pharmaceuticals, Inc. on Form S-8, of our report dated March 25, 2009 for the year ended December 31, 2008, appearing in the Annual Report on Form 10-K of Biostar Pharmaceuticals, Inc. Morgenstern, Svoboda & Baer CPA’s P.C. New York, New York]
[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-5101287 (State of other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) No. 588 Shiji Xi Road, Xianyang, Shaanxi Province, The People’s Republic of China 712046 (Zip Code) Biostar Pharmaceuticals, Inc. 2009 Incentive Stock Plan (Full Title of Plan) Mr. Ronghua Wang No. 588 Shiji] [BIOSTAR PHARMACEUTICALS, INC. 2009 INCENTIVE STOCK PLAN This Biostar Pharmaceuticals, Inc. 2009 Incentive Stock Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee "] [August 28, 2009 Biostar Pharmaceuticals, Inc. Xianyang, Shaanxi Province The People’s Republic of China 712046 Ladies and Gentlemen: Very truly yours, Sichenzia Ross Friedman Ference LLP Title 41 EX-5.1 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM We consent to the incorporation by reference in this registration statement of Biostar Pharmaceuticals, Inc. on Form S-8, of our report dated March 25, 2009 for the year ended December 31, 2008, appearing in the Annual Report on Form 10-K of Biostar Pharmaceuticals, Inc. Morgenstern, Svoboda & Baer CPA’s P.C. New York, New York]
[CONTENTS Chapter 1 Important Notice 1 Chapter 2 Basic Information on the Company 2 Chapter 3 Change in Share Capital and Shareholding of Major Shareholders 7 Chapter 4 Directors, Supervisors and Senior Management 12 Chapter 5 13 Chapter 6 Matters of Importance 24 Chapter 7 Financial Report (unaudited) 31 Chapter 8 Documents Available for Inspection 56] [TABLE OF CONTENTS 99.1: 2009 Interim Results dated August 26,2009 2 Guangshen Railway Company Limited Dated: August 27, 2009 Guo Xiang Dong Company Secretary 3 6-K 1 h03609e6vk.htm GUANGSHEN RAILWAY COMPANY LIMITED]
[CONTENTS Chapter 1 Important Notice 1 Chapter 2 Basic Information on the Company 2 Chapter 3 Change in Share Capital and Shareholding of Major Shareholders 7 Chapter 4 Directors, Supervisors and Senior Management 12 Chapter 5 13 Chapter 6 Matters of Importance 24 Chapter 7 Financial Report (unaudited) 31 Chapter 8 Documents Available for Inspection 56] [TABLE OF CONTENTS 99.1: 2009 Interim Results dated August 26,2009 2 Guangshen Railway Company Limited Dated: August 27, 2009 Guo Xiang Dong Company Secretary 3 6-K 1 h03609e6vk.htm GUANGSHEN RAILWAY COMPANY LIMITED]
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Reports First and Second Quarter 2009 Unaudited Financial Results Shanghai, China August 27, 2009. First Quarter 2009 Financial Highlights: Net revenues for the first quarter of 2009 increased by 4% quarter-over-quarter and decreased by 3% year-over-year to RMB426.2 million (US$62.4 million). Net loss for the first]
[THE9 LIMITED Jun Zhu Chairman and Chief Executive Officer The9 Limited Reports First and Second Quarter 2009 Unaudited Financial Results Shanghai, China August 27, 2009. First Quarter 2009 Financial Highlights: Net revenues for the first quarter of 2009 increased by 4% quarter-over-quarter and decreased by 3% year-over-year to RMB426.2 million (US$62.4 million). Net loss for the first]
[Page 1.1 Announcement of Interim Results for the Six Months ended June 30, 2009, dated August 27, 2009. A-1 1.2 Reconciliation of Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) (Excluding CDMA Network Capacity Lease Fee) to Net Cash from Operating Activities, dated August 27, 2009. B-1 2]
